Matthew R. Hudson

ORCID: 0000-0001-5016-735X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroscience and Neuropharmacology Research
  • Neural dynamics and brain function
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Epilepsy research and treatment
  • Stress Responses and Cortisol
  • Receptor Mechanisms and Signaling
  • Neurotransmitter Receptor Influence on Behavior
  • Traumatic Brain Injury Research
  • Pharmacological Effects and Toxicity Studies
  • Advanced Neuroimaging Techniques and Applications
  • Advanced MRI Techniques and Applications
  • Memory and Neural Mechanisms
  • Neuroscience and Neural Engineering
  • Tryptophan and brain disorders
  • Alzheimer's disease research and treatments
  • Photoreceptor and optogenetics research
  • Cerebrospinal fluid and hydrocephalus
  • Neuroendocrine regulation and behavior
  • Functional Brain Connectivity Studies
  • S100 Proteins and Annexins
  • Neonatal and fetal brain pathology
  • Menopause: Health Impacts and Treatments
  • Drug Transport and Resistance Mechanisms
  • Mitochondrial Function and Pathology
  • Fetal and Pediatric Neurological Disorders

Monash University
2018-2025

Alfred Health
2023-2025

The Royal Melbourne Hospital
2016-2023

The University of Melbourne
2016-2023

The Alfred Hospital
2019-2022

There are no treatments in clinical practice known to mitigate the neurobiological processes that convert a healthy brain into an epileptic one, phenomenon as epileptogenesis. Downregulation of protein phosphatase 2A, causes hyperphosphorylation tau, is implicated neurodegenerative diseases commonly associated with epilepsy, such Alzheimer's disease and traumatic injury. Here we used 2A activator sodium selenate investigate role three different rat models epileptogenesis: amygdala kindling,...

10.1093/brain/aww116 article EN Brain 2016-06-11

Abstract Recent heuristic models of schizophrenia propose that abnormalities in the gamma frequency cerebral oscillations may be closely tied to pathophysiology disorder, with hypofunction N -methyl- d -aspartate receptors (NMDAr) implicated as having a crucial role. Prepulse inhibition (PPI) is behavioural measure sensorimotor gating disrupted schizophrenia. We tested ability for antipsychotic drugs diverse pharmacological actions (1) ameliorate NMDAr antagonist-induced disruptions and (2)...

10.1038/tp.2016.51 article EN cc-by Translational Psychiatry 2016-04-19

Abstract Traumatic brain injury (TBI) presents a major global health concern, characterized by variety of negative long term neurological outcomes. Current diagnostic tools lack the sensitivity to fully capture complex pathophysiology TBI and predict long-term consequences, underscoring need for robust methods biomarker detection. This study, conducted within multicenter Epilepsy Bioinformatics Study Antiepileptogenic Therapy (EpiBioS4Rx) framework, used standardized lateral fluid-percussion...

10.1162/imag_a_00471 article EN cc-by Imaging Neuroscience 2025-01-01

NMDAr antagonists induce disturbances to gamma frequency oscillations, including increasing ongoing activity and reducing evoked oscillations. We sought investigate the role parvalbumin (PV+) neurons CaMKIIα+ pyramidal cells in antagonist-induced oscillatory relate these common behavioural consequences of drugs by selectively deleting obligatory GluN1 subunit from mice. Adult mice (total n = 99) with deleted PV interneurons (PV:GluN1 KO) or (CaMKIIα:GluN1 KO), WT littermates, were used....

10.1016/j.nbd.2019.104625 article EN cc-by-nc-nd Neurobiology of Disease 2019-11-28

Abstract Objective Many people with epilepsy experience comorbid anxiety and depression, antidepressants remain a primary treatment for this. Emerging evidence suggests that these agents may modulate epileptogenesis to influence disease severity. Here, we assessed how the selective serotonin reuptake inhibitor (SSRI) antidepressant fluoxetine impacts epileptogenic, behavioral, pathological sequelae following status epilepticus. Methods Male Wistar rats received kainic acid induce epilepticus...

10.1111/epi.18080 article EN cc-by Epilepsia 2024-08-05

Schizophrenia is a complex psychiatric disorder with heterogeneous aetiology involving genetic and environmental factors. Deficiencies in both brain-derived neurotrophic factor (BDNF) NMDA receptor function have been implicated the may play causal synergistic roles. Perturbations regulation of electrophysiological signals, including high-frequency (γ: 30-80 Hz β: 20-30 Hz) neuronal oscillations, are also associated disorder. This study investigated influence BDNF deficiency hypofunction on...

10.1111/ejn.13722 article EN European Journal of Neuroscience 2017-09-19

Background: Abnormalities in neural oscillations that occur the gamma frequency range (30–80 Hz) may underlie cognitive deficits schizophrenia. Both impairments and oscillatory disturbances can be induced healthy people rodents by administration of N-methyl-D-aspartate receptor (NMDAr) antagonists. Aims: We studied relationships between impairment abnormalities following NMDAr antagonism, attempted to reverse with metabotropic glutamate type 2/3 (mGluR ) agonist LY379268. Methods: C57/Bl6...

10.1177/0269881119875976 article EN Journal of Psychopharmacology 2019-10-03

Project 1 of the Preclinical Multicenter Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) consortium aims to identify preclinical biomarkers antiepileptogenic therapies following traumatic brain injury (TBI). The international participating centers in Finland, Australia, and United States have made a concerted effort ensure protocol harmonization. Here, we evaluate success harmonization process by assessing timing, coverage, performance between study sites.

10.1016/j.eplepsyres.2023.107263 article EN cc-by Epilepsy Research 2023-11-24

Post-traumatic epilepsy (PTE) occurs in some patients following moderate/severe traumatic brain injury (TBI). While there are no approved therapies to prevent epileptogenesis, levetiracetam (LEV) is commonly given for seizure prophylaxis due its good safety profile. This led us study LEV as part of the Epilepsy Bioinformatics Study Antiepileptogenic Therapy (EpiBioS4Rx) Project. The objective this work characterize pharmacokinetics (PK) and uptake naïve control rats lateral fluid percussion...

10.1124/jpet.122.001377 article EN cc-by-nc Journal of Pharmacology and Experimental Therapeutics 2023-06-14

Abstract Noncompetitive NMDA receptor (NMDAR) antagonists like phencyclidine (PCP) and ketamine cause psychosis‐like symptoms in healthy humans, exacerbate schizophrenia people with the disorder, disrupt a range of schizophrenia‐relevant behaviors rodents, including hyperlocomotion. This is negated mice lacking GluN2D subunit NMDAR, suggesting mediates hyperlocomotor effects these drugs. However, role mediating other NMDAR antagonist‐induced behavioral disturbances, both sexes, unclear....

10.1002/jnr.25257 article EN cc-by Journal of Neuroscience Research 2023-10-10

The 5xFAD mouse model of Alzheimer disease (AD) recapitulates amyloid-beta (Aβ) deposition and pronounced seizure susceptibility observed in patients with AD. Forty-hertz audiovisual stimulation is a noninvasive technique that entrains gamma neural oscillations can reduce Aβ pathology modulate glial expression AD models. We hypothesized 40-Hz sensory would improve mice this be associated reduction plaques modulation phenotypes.

10.1111/epi.18222 article EN Epilepsia 2024-12-30

Schizophrenia is a complex neuropsychiatric disorder characterized by psychoses, socioaffective disturbances, and cognitive deficits. The phosphodiesterase enzyme phospholipase C-β1 has been reported to be reduced in postmortem tissue of schizophrenia patients. Dysregulation neuronal oscillations, particularly those the higher frequency range such as beta (12–30 Hz) gamma (30–80 Hz), are also associated with this disorder. We investigated influence gene deletion on cortical oscillatory...

10.1093/ijnp/pyy097 article EN cc-by-nc The International Journal of Neuropsychopharmacology 2018-11-30
Coming Soon ...